Epigenetic regulation and metabolism are of great interest in cancer research. However, physical and functional connections between these two areas remain largely unexplored. While it is commonly believed that metabolites can rand...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
MetEpiC
P53 dependent Metabolic and Epigenetic Reprogramming in Carc...
197K€
Cerrado
EpiMetaPDO
Dissecting mechanisms of epigenetic reprogramming driving me...
173K€
Cerrado
CANCER EPIGENETICS
Comprehensive characterization of epigentic reprogramming in...
100K€
Cerrado
EVOEPIC
Evolutionary mechanisms of epigenomic and chromosomal aberra...
1M€
Cerrado
RTI2018-094049-B-I00
DISRUPCION EPIGENETICA Y GENETICA DE LAS MODIFICACIONES DEL...
Cerrado
MultiplexGenomics
Exploring the Epigenome by Multiplexed Physical Mapping of I...
3M€
Cerrado
Información proyecto EPICAMENTE
Duración del proyecto: 72 meses
Fecha Inicio: 2019-10-11
Fecha Fin: 2025-10-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Epigenetic regulation and metabolism are of great interest in cancer research. However, physical and functional connections between these two areas remain largely unexplored. While it is commonly believed that metabolites can randomly distribute inside the cell, recent evidence rather favors the hypothesis that production of certain metabolites in specific subcellular compartments orchestrates different cellular processes. EPICAMENTE aims at exploring whether the localization of enzymatic activities on chromatin can integrate cancer metabolism with chromatin remodeling to control epigenetic regulation and tumor progression. First, I aim at providing a dataset of chromatin-bound metabolic enzymes in a comprehensive panel of cancer cell lines. By combining a chromatin fluorescent reporter cell line strategy with epigenomic approaches, I will define the epigenetic and transcriptional scenarios orchestrated by chromatin-bound metabolic enzymes, and investigate their relevance in cancer cell proliferation. Performing genetic screenings with the chromatin fluorescent reporter cell lines will allow the identification of genetic interactors mediating the epigenetic role of chromatin-bound metabolic enzymes. In parallel, I aim to screen for small molecules able to counteract the epigenetic states mediated by those metabolic enzymes. Finally, I will validate my results in in vivo cancer models, thus adding an important translational aspect to the project, and opening up new opportunities for cancer therapy. The success of this project can impact our fundamental understanding of cellular and cancer biology. In most cases, the belief is that intracellular materials reside inside steady-state membrane-based compartments, which limit the interactions between different molecular pathways. By describing the role of chromatin-bound metabolic enzymes and discovering direct connections between cancer metabolism and epigenetic regulation, I will scrutinize this belief.